ME01612B - Proces za pripremu 4-[(1,6-dihidro-6-okso-2-pirimidinil)amino benzonitrila - Google Patents

Proces za pripremu 4-[(1,6-dihidro-6-okso-2-pirimidinil)amino benzonitrila

Info

Publication number
ME01612B
ME01612B MEP-2013-136A MEP13613A ME01612B ME 01612 B ME01612 B ME 01612B ME P13613 A MEP13613 A ME P13613A ME 01612 B ME01612 B ME 01612B
Authority
ME
Montenegro
Prior art keywords
dihydro
oxo
pyrimidinyl
preparing
ester
Prior art date
Application number
MEP-2013-136A
Other languages
English (en)
Unknown language (me)
Inventor
Didier Philippe Robert Schils
Alfred Elisabeth Stappers
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35822492&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01612(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of ME01612B publication Critical patent/ME01612B/me

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MEP-2013-136A 2005-05-26 2006-05-24 Proces za pripremu 4-[(1,6-dihidro-6-okso-2-pirimidinil)amino benzonitrila ME01612B (me)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05104531 2005-05-26
US68599305P 2005-05-31 2005-05-31
PCT/EP2006/062606 WO2006125809A1 (en) 2005-05-26 2006-05-24 Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile
EP06755299.2A EP1888537B1 (en) 2005-05-26 2006-05-24 Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile

Publications (1)

Publication Number Publication Date
ME01612B true ME01612B (me) 2014-09-20

Family

ID=35822492

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2013-136A ME01612B (me) 2005-05-26 2006-05-24 Proces za pripremu 4-[(1,6-dihidro-6-okso-2-pirimidinil)amino benzonitrila

Country Status (19)

Country Link
US (2) US8101752B2 (en17)
EP (1) EP1888537B1 (en17)
JP (2) JP5148483B2 (en17)
CN (1) CN101248051B (en17)
AU (1) AU2006251163C1 (en17)
BR (1) BRPI0611038B8 (en17)
CA (1) CA2609716C (en17)
DK (1) DK1888537T3 (en17)
ES (1) ES2437202T3 (en17)
HR (1) HRP20131133T1 (en17)
IN (1) IN2014DN04588A (en17)
ME (1) ME01612B (en17)
MX (1) MX2007014881A (en17)
PL (1) PL1888537T3 (en17)
PT (1) PT1888537E (en17)
RS (1) RS53062B (en17)
RU (1) RU2458056C2 (en17)
SI (1) SI1888537T1 (en17)
WO (1) WO2006125809A1 (en17)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006125809A1 (en) * 2005-05-26 2006-11-30 Tibotec Pharmaceuticals Ltd Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile
WO2012125993A1 (en) 2011-03-17 2012-09-20 Teva Pharmaceutical Industries Ltd. Solid state forms of rilpivirine base, and rilipivirine salts
WO2013135684A1 (en) 2012-03-13 2013-09-19 Octapharma Ag Improved process for production of fibrinogen and fibrinogen produced thereby
CN103058936B (zh) * 2013-01-23 2016-01-06 宁波九胜创新医药科技有限公司 4-[(4-氯-2-嘧啶基)氨基]苯腈的制备方法
CN103193719B (zh) * 2013-04-08 2015-07-22 宁波九胜创新医药科技有限公司 一种4-[(4-羟基-2-嘧啶基)氨基]苯腈的制备方法
CN114933567B (zh) * 2022-04-29 2023-07-11 武汉工程大学 一种2-甲硫基-4-嘧啶酮的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63502B1 (en) 1989-04-21 1995-05-03 Zeneca Ltd Aminopyrimidine derivatives useful for treating cardiovascular disorders
RU2037483C1 (ru) * 1989-07-20 1995-06-19 Мерк Патент Гмбх Способ получения замещенных ароматических нитрилов
DE3923979A1 (de) 1989-07-20 1991-01-24 Merck Patent Gmbh Verfahren zur herstellung von aromatischen nitrilen
WO1999050250A1 (en) * 1998-03-27 1999-10-07 Janssen Pharmaceutica N.V. Hiv inhibiting pyrimidine derivatives
EE05086B1 (et) * 1998-11-10 2008-10-15 Janssen Pharmaceutica N.V. Primidiini derivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod, kombinatsioon ning saadus
BRPI0014271B1 (pt) * 1999-09-24 2021-06-22 Janssen Pharmaceutica N.V. Partícula consistindo em uma dispersão de sólidos, uso da dita partícula, dispersão de sólidos, forma de dosagem farmacêutica, bem como processos de preparação de dita partícula, dispersão e forma de dosagem
EP1282607B1 (en) * 2000-05-08 2015-11-11 Janssen Pharmaceutica NV Prodrugs of hiv replication inhibiting pyrimidines
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
MXPA04004178A (es) * 2001-11-01 2004-09-06 Janssen Pharmaceutica Nv Heteroarilaminas como inhibidores de glucogeno cintasa cinasa 3beta.
AU2003266413B2 (en) * 2002-08-09 2009-04-02 Janssen Pharmaceutica N.V. Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
AU2004286933B2 (en) * 2003-09-30 2010-11-18 Janssen Pharmaceutica N.V. Benzoimidazole compounds
WO2006125809A1 (en) * 2005-05-26 2006-11-30 Tibotec Pharmaceuticals Ltd Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile

Also Published As

Publication number Publication date
CN101248051B (zh) 2013-07-17
US8101752B2 (en) 2012-01-24
EP1888537B1 (en) 2013-09-11
DK1888537T3 (da) 2013-12-09
HK1123551A1 (en) 2009-06-19
WO2006125809A1 (en) 2006-11-30
AU2006251163B2 (en) 2012-03-08
RS53062B (en) 2014-04-30
JP2008545680A (ja) 2008-12-18
RU2007148968A (ru) 2009-07-10
US20120083606A1 (en) 2012-04-05
HRP20131133T1 (hr) 2014-01-03
US20080171878A1 (en) 2008-07-17
US8618291B2 (en) 2013-12-31
ES2437202T3 (es) 2014-01-09
BRPI0611038B8 (pt) 2022-10-25
RU2458056C2 (ru) 2012-08-10
BRPI0611038B1 (pt) 2022-02-08
JP2013040194A (ja) 2013-02-28
CN101248051A (zh) 2008-08-20
AU2006251163A1 (en) 2006-11-30
EP1888537A1 (en) 2008-02-20
IN2014DN04588A (en17) 2015-07-10
PT1888537E (pt) 2013-11-26
JP5148483B2 (ja) 2013-02-20
CA2609716C (en) 2014-10-14
SI1888537T1 (sl) 2014-01-31
BRPI0611038A2 (pt) 2010-08-10
CA2609716A1 (en) 2006-11-30
MX2007014881A (es) 2008-02-15
JP5580385B2 (ja) 2014-08-27
AU2006251163C1 (en) 2012-07-12
PL1888537T3 (pl) 2014-02-28

Similar Documents

Publication Publication Date Title
ME01612B (me) Proces za pripremu 4-[(1,6-dihidro-6-okso-2-pirimidinil)amino benzonitrila
DK2057126T3 (da) Fremgangsmåde til fremstilling af 3-dihalomethyl-pyrazol-4-carboxylsyrederivater
DK1881957T3 (da) Fremgangsmåde til fremstilling af biproduktfattige methylglycin-N,N-diedikkesyre-trialkalimetalsalte
EP3725801A3 (en) Amino diacids containing peptide modifiers
EA200970149A1 (ru) Производные n-(аминогетероарил)-1h-индол-2-карбоксамидов, их получение и их применение в терапии
MY175373A (en) Crystal form of phenylamino pyrimidine derivatives
MX2009005768A (es) Proceso para producir condimento.
BRPI0905147A8 (pt) processo para síntese de ivabradina e seus sais de adição com um ácido farmaceuticamente aceitável
TW200640918A (en) Isoxazoline derivative and novel process for its preparation
TW200716138A (en) Stable active compound complex of salts of O-acetylsalicylic acid with basic amino acids and glycine
MY148411A (en) Process for stably operating a continuous preparation process for obtaining acrolein or acrylic acid or a mixture thereof from propane
UA100367C2 (uk) Спосіб одержання мемантину і його гідрохлориду
NO20082749L (no) Fremgangsmate for fremstilling av ferri-succinylkasein
TW200720243A (en) Process for stably operating a continuous preparation process for obtaining acrolein or acrylic acid or a mixture thereof from propane
PH12012502453A1 (en) Method of synthesis of ferroquine by convergent reductive amination
CY1113279T1 (el) Φαρμακευτικη συνθεση 271
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
CR9565A (es) Derivados del 4,5-diarilpirrol, su preparacion y su aplicacion en terapeutica
TW200722434A (en) Stereoselective synthesis of β-nucleosides
EA201171467A1 (ru) Способ получения композиции, содержащей антивинную кислоту
RS63804A (en) Stable salts of o-acetylsalicylic acid containing basic amino acids ii
ATE438612T1 (de) Neuartiges verfahren zur herstellung von quaternärer säure und ammoniumsalzen
ATE550326T1 (de) Als modulatoren von hdl einsetzbare verbindungen
MX2009007598A (es) Hexahidrato de enrofloxacino.
DK1819704T3 (da) Pyrrolopyridin-2-carboxylsyre-amid-derivat anvendelig som inhibitor af glycogenphosphorylase